A diagnosis of fatty liver using controlled attenuation parameter (CAP) loading Fibroscan and a comparative analysis with clinical data

A diagnosis of fatty liver using controlled attenuation parameter (CAP) loading Fibroscan and a comparative analysis with clinical data - A utility of quantitative controlled attenuation parameter (CAP) loading Fibroscan to diagnose fatty liver

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013046

Enrollment

530

Registered

2014-02-02

Start date

2014-01-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormality of liver function

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with an abnormality of liver function who got the informed consent for this study.

Exclusion criteria

Exclusion criteria: the patient who did not get the informed consent for this study.

Design outcomes

Primary

Measure	Time frame
CAP score(the evaluation of liver fat content:Fibroscan)	—

Secondary

Measure	Time frame
Liver stiffness(Fibroscan),physical parameters, blood biochemical values and ultrasound scanning.	—

Countries

Japan

Contacts

Public ContactMasahiro Kikuchi

Tokai University School of Medicine Dept. of Gastroenterology

kikuchim490611@yahoo.co.jp81-3-3370-2321

Outcome results